10 Pharmaceutical Companies Shut after Surprise Inspection

.

10 Pharmaceutical Companies Shut after Surprise Inspection

Massachusetts health department has revealed that after unexpected inspections, 10 pharmaceutical companies have been asked to close down their work temporarily.

Around 40 companies were visited by a team of inspectors. It was preceded by the news of New England Compounding Center (NECC) in Framingham, Mass., shipping vessels of injectable methylprednisolone getting infected with mold to clinics across the country.

These infected steroid products were utilized for spinal injections. Reports have said the administration of the steroid had led to an outbreak of fungal meningitis.

Besides ordering 10 pharmacies to stop their work, one company has been commanded to stop the production of one particular drug, sildenafil citrate. The Department of Health said they saw 21 pharmaceutical companies violating small laws but they have been provided permission to continue their sterile drug production.

Cease-and-desist letters were sent immediately after the inspection was done. These letters were notified to 11 pharmacy companies. This was revealed in a statement released by the state's Department of Public Health.

The Department of Health said the companies have responded well to the directions provided to safeguard the law. Earlier it was seen that three fundamental companies of the state met with an annulment of their licenses.

According to FDA Commissioner Margaret Hamburg, substandard and illegal practices will meet the same fate in future as well.


Latest News

Rise in Russian Arms Sales In spite of a Drop Globally
PetSmart Sells itself with an $8.3Billion Deal
Falling Oil Prices Result in a Drop in Stocks
Shares of Amaya Fall Due to Probe Conducted by Securities Regulators
Americans Consumers Display Confidence In the Market with Gain in Sales
It’s Time to Hurry Up to Enrol in the First Phase of Affordable Care Act Health
After Merger with Alliance Boots,	Walgreen CEO will Retire
Falling Fuel Prices Lift Airline Profits But No Respite in Fares Expected
Citigroup to Pay Likely $2.7B as Legal Charge
Michael Jeffries Retires as the CEO of Abercrombie & Fitch
Deutsche Bank in Trouble Again in the U.S. for Alleged Tax Scheme
Popular Demand Brings French Toast Crunch Back on the Shelves